LIXTE BIOTECHNOLOGY HOLDINGS, INC. (22) | Business Operations (2)

Browse by Subcategory

Sales Agreements (1)
Services Agreements (1)

Recent Contracts

Sales Agreement dated as of September 20, 2021 between Lixte Biotechnology Holdings, Inc. and WestPark Capital, Inc (Filed With SEC on September 20, 2021)
Master Service Agreement with Foundation of Angelman Syndrome Therapeutics FAST (Filed With SEC on August 18, 2020)